Daiichi Sankyo News
Most Popular Daiichi Sankyo Story
Daiichi Sankyo acquires Ranbaxy in $4.6B deal
Ranbaxy's drive to become a research-based drug developer and major manufacturer has led it straight into the Read more...
Latest Headlines
- November 10, 2011
- April 12, 2011
- March 1, 2011
- February 7, 2011
- November 13, 2009
- July 13, 2009
- February 24, 2009
- February 4, 2009
- January 14, 2009
- November 10, 2008
- October 17, 2008
- September 29, 2008
- July 23, 2008
- June 24, 2008
- June 13, 2008
- June 11, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
